Sherry Mohamed Khater

Sherry Mohamed Khater

Auto-generated profile, based on publicly available information

Sherry Mohamed Khater

Department of Pathology, Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MGMahmoud M. Gabr
Mahmoud M. Gabr
MZMahmoud Zakaria
Mahmoud Zakaria
ARAyman F. Refaie
Ayman F. Refaie
EAEngy A. Abdel-Rahman
Engy A. Abdel-Rahman
ARAsmaa M. Reda
Asmaa M. Reda
MGMohamed A. Ghoneim
Mohamed A. Ghoneim
The aim of this study is to compare human bone marrow-derived mesenchymal stem cells (BM-MSCs) and adipose tissue-derived mesenchymal stem cells (AT-MSCs), for their differentiation potentials to form insulin-producing cells. BM-MSCs were obtained during elective orthotopic surgery and AT-MSCs from fatty aspirates during elective cosmetics procedures. Following their expansion, cells were characterized by phenotyping, trilineage differentiation ability, and basal gene expression of pluripotency genes and for their metabolic characteristics. Cells were differentiated according to a Trichostatin-A based protocol. The differentiated cells were evaluated by immunocytochemistry staining for insulin and c-peptide. In addition the expression of relevant pancreatic endocrine genes was determined. The release of insulin and c-peptide in response to a glucose challenge was also quantitated. There were some differences in basal gene expression and metabolic characteristics. After differentiation the proportion of the resulting insulin-producing cells (IPCs), was comparable among both cell sources. Again, there were no differences neither in the levels of gene expression nor in the amounts of insulin and c-peptide release as a function of glucose challenge. The properties, availability, and abundance of AT-MSCs render them well-suited for applications in regenerative medicine.Conclusion. BM-MSCs and AT-MSCs are comparable regarding their differential potential to form IPCs. The availability and properties of AT-MSCs render them well-suited for applications in regenerative medicine.

2 January 2019 in Egyptian Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
MZMahmoud Zakaria
Mahmoud Zakaria
FEFatma Mohamed Mansour El-Tantawy
Fatma Mohamed Mansour El-Tantawy
SKSherry Mohamed Khater
Sherry Mohamed Khater
SDSafaa A. Derbala
Safaa A. Derbala
VFVerginia Mohamed El-Metwally Farag
Verginia Mohamed El-Metwally Farag
AAAbdel-Aziz Fatouh Abdel-Aziz
Abdel-Aziz Fatouh Abdel-Aziz
Cisplatin (Cp) is an anti-neoplastic drug. Nephrotoxicity is the major side effect of Cp. Spirulina (Sp) is a blue-green alga with the ability to alleviating side effects of chemotherapeutic drugs in clinic. The aim of the study was to evaluate the ability of Sp to protect from cisplatin-induced nephrotoxicity. Adult male rat was orally administered Sp two days before single dose of Cp over 21 days (Sp + Cp group), 2nd group that intake Sp two days after with the same dose of Cp (Cp + Sp group) and two further groups were served as controls treated with either Sp or Cp only, respectively, as well as normal healthy control was included. At the end of experiment, Cp drug was induced acute kidney injury elevated levels of BUN, creatinine, KIM-1, NGAL and microalbumin in significant compared to that of normal control group, while the opposite effects were found in the rats who received Sp only. Furthermore, the prophylactic group showed improvements in biochemical parameters compared to those received Cp only. The effects of Cp were found to be diminished in the treated group. In addition, evaluation of Bax and SIRT genes expression in combination with histomorphological alterations of the kidney indicated the protective effect of Sp against Cp. In conclusion, pretreatment with Sp protected Cp-induced nephrotoxicity, probably via its antiapoptotic properties.

21 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MGMahmoud M Gabr
Mahmoud M Gabr
MZMahmoud Zakaria
Mahmoud Zakaria
ARAyman F Refaie
Ayman F Refaie
SKSherry M Khater
Sherry M Khater
SASylvia A Ashamallah
Sylvia A Ashamallah
MGMohamed A Ghoneim
Mohamed A Ghoneim
Mesenchymal stem cells (MSCs) can be differentiated in vitro to form insulin‐producing cells (IPCs). However, the proportion of induced cells is modest. Extracts from injured pancreata of rodents promoted this differentiation, and three upregulated proteins were identified in these extracts. The aim of this study was to evaluate the potential benefits of adding these proteins to the differentiation medium alone or in combination. Our results indicate that the proportion of IPCs among the protein(s)‐supplemented samples was significantly higher than that in the samples with no added proteins. The yield from samples supplemented with PRDX6 alone was 4‐fold higher than that from samples without added protein. These findings were also supported by the results of fluorophotometry. Gene expression profiles revealed higher levels among protein‐supplemented samples. Significantly higher levels of GGT, SST, Glut‐2, and MafB expression were noted among PRDX6‐treated samples. There was a stepwise increase in the release of insulin and c‐peptide, as a function of increasing glucose concentrations, indicating that the differentiated cells were glucose sensitive and insulin responsive. PRDX6 exerts its beneficial effects as a result of its biological antioxidant properties. Considering its ease of use as a single protein, PRDX6 is now routinely used in our differentiation protocols.

1 January 2025 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
ANAhmed Nashat
Ahmed Nashat
AAAhmed AlKsas
Ahmed AlKsas
Rasha AbouelkheirRasha Abouelkheir
Rasha Abouelkheir
AEAhmed Elmahdy
Ahmed Elmahdy
SKSherry M. Khater
Sherry M. Khater
AAAhmed Abdelhalim
Ahmed Abdelhalim
Nashat A, et al. Investig Clin Urol. 2025 Jan;66(1):47-55. https://doi.org/10.4111/icu.20240135